unlearn

Unlearn is a technology company based in San Francisco, California, with an additional office in Cambridge, Massachusetts. Founded in 2017, the company focuses on using artificial intelligence to enhance clinical trials and improve health outcomes. Unlearn aims to redefine medicine by creating AI-generated digital twins of clinical trial participants, which help predict future health outcomes with high precision.

The Unlearn Platform is an AI-driven solution that generates these digital twins using only baseline data from participants. This innovative approach allows for the design and execution of smaller randomized controlled trials while maintaining statistical power. The platform supports informed decision-making during trials, refines inclusion/exclusion criteria, and enhances trial efficiency across various therapeutic areas, including neuroscience and immunology. Unlearn's technology is utilized by leading biopharmaceutical companies to streamline clinical trials and accelerate the delivery of new treatments to patients.